Item 7.01 Regulation FD Disclosure.

Waters Corporation (the "Company") is furnishing as Exhibit 99.1 to this Current Report on Form 8-K an investor presentation (the "Presentation") that it intends to present at the J.P. Morgan Healthcare Conference (the "Conference") on January 9, 2023, which, along with the subsequent Q&A session, will include high-level commentary on business performance. A transcript of the Presentation will be available following the Presentation on the Waters Corporation website www.waters.com in the Investors section under Investor Presentations.

The information contained in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly provided by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Number      Description of Exhibits

99.1          Investor Presentation dated January 9, 2023.

104         The cover page from this Current Report on Form 8-K, formatted in
            Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses